RPS26P41

Across TCGA pan-cancer cohorts, RPS26P41 RNA differs between tumor and matched normal tissue in 11 of 18 cancer types tested, making tumor–normal expression one of RPS26P41’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where RPS26P41 RNA is repressed in tumor relative to normal tissue. In most cancer types RPS26P41 is over-expressed in tumor, although a few such as THCA and KIRC show the opposite, repressed pattern.

THCA, KIRC, and READ are the cancer types where RPS26P41 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPS26P41 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	Female	II,III,IV	−0.767	<.001	7	view →
KIRC	All	III,IV	−0.090	<.001	5	view →
READ	All	All	+0.506	.005	3	view →
ESCA	All	II,III,IV	+0.954	.031	2	view →
PRAD	All	All	+0.330	.013	2	view →
CHOL	All	II,III,IV	+0.325	<.001	2	view →
LUSC	Male	All	−0.226	.015	2	view →
COAD	All	All	+0.204	.039	2	view →
KIRP	All	IV	+0.180	.030	2	view →
HNSC	All	III,IV	+0.150	.046	2	view →
LIHC	All	All	+0.021	.047	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 11 strongest of 11 lineages.

RPS26P41–THCA

Open the THCA breakdown →